STOCK TITAN
  1. Home
  2. Sec-filings
  3. MRMD
  4. [Form 4] MARIMED INC. Insider Trading Activity

MariMed (MRMD) COO receives 170,625 RSUs, holds 9.36M shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

MariMed Inc. Chief Operating Officer Timothy Shaw received a grant of 170,625 Restricted Stock Units (RSUs). The RSUs convert to common stock on a one-for-one basis and vest in four equal installments on July 15, 2026, October 15, 2026, January 15, 2027 and April 15, 2027.

After this award, Shaw reports 9,357,700 shares of MariMed common stock held directly, plus 170,625 RSUs. An additional 2,000,000 shares are held indirectly by the Shaw Family Trust for his children, for which he disclaims beneficial ownership.

Positive

  • None.

Negative

  • None.
Insider Shaw Timothy
Role Chief Operating Officer
Type Security Shares Price Value
Grant/Award Restricted Stock Units (RSU) 170,625 $0.00 --
holding Common stock -- -- --
holding Common stock -- -- --
Holdings After Transaction: Restricted Stock Units (RSU) — 170,625 shares (Direct); Common stock — 9,357,700 shares (Direct); Common stock — 2,000,000 shares (Indirect, By the Shaw Family Trust)
Footnotes (1)
  1. The Reporting Person's spouse is the trustee of the trust and the shares held in the trust are for the benefit of the Reporting Person's children. The trust is an irrevocable trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. RSUs convert to shares of common stock on a one-for-one basis. The RSUs will vest in four equal installments on each of July 15, 2026, October 15, 2026, January 15, 2027 and April 15, 2027.
RSU grant size 170,625 RSUs Awarded on April 15, 2026; convert 1:1 into common stock
RSU vesting schedule 4 equal installments Vesting on July 15, 2026; October 15, 2026; January 15, 2027; April 15, 2027
Direct common shares held 9,357,700 shares Total MariMed common stock held directly after the reported award
Indirect trust holdings 2,000,000 shares Held by the Shaw Family Trust for Shaw’s children; beneficial ownership disclaimed
RSU conversion ratio 1:1 Each RSU converts into one share of common stock upon vesting
Restricted Stock Units (RSU) financial
"RSUs convert to shares of common stock on a one-for-one basis."
irrevocable trust financial
"The trust is an irrevocable trust."
Section 16 financial
"not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16"
Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.
vesting financial
"The RSUs will vest in four equal installments on each of July 15, 2026, October 15, 2026, January 15, 2027 and April 15, 2027."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Shaw Timothy
(Last)(First)(Middle)
C/O MARIMED INC.
10 OCEANA WAY
(Street)
NORWOOD, MASSACHUSETTS 02062
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
MARIMED INC. [ MRMD ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Operating Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/15/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common stock9,357,700D
Common stock2,000,000IBy the Shaw Family Trust(1)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units (RSU)(2)04/15/2026A170,625 (3) (3)Common Stock, par value $.001 per share170,625$0170,625D
Explanation of Responses:
1. The Reporting Person's spouse is the trustee of the trust and the shares held in the trust are for the benefit of the Reporting Person's children. The trust is an irrevocable trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
2. RSUs convert to shares of common stock on a one-for-one basis.
3. The RSUs will vest in four equal installments on each of July 15, 2026, October 15, 2026, January 15, 2027 and April 15, 2027.
Remarks:
The RSUs were granted in lieu of cash payment of a portion of the Reporting Person's annual bonus for the fiscal year ended December 31, 2025.
/s/ Timothy Shaw04/16/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did MariMed (MRMD) COO Timothy Shaw report?

Timothy Shaw reported receiving a grant of 170,625 Restricted Stock Units (RSUs). These RSUs are a stock-based compensation award, not an open-market purchase, and will convert into MariMed common shares over time as they vest through 2027.

How many RSUs were granted to MariMed (MRMD) COO Timothy Shaw and when do they vest?

Shaw was granted 170,625 RSUs that vest in four equal installments. Vesting dates are July 15, 2026, October 15, 2026, January 15, 2027, and April 15, 2027, after which vested units convert into common shares on a one-for-one basis.

How many MariMed (MRMD) common shares does Timothy Shaw hold directly after this Form 4?

Following the reported award, Shaw holds 9,357,700 shares of MariMed common stock directly. He also reports 170,625 RSUs representing potential future shares upon vesting, separate from his existing direct common stock holdings.

What is the Shaw Family Trust’s position in MariMed (MRMD) shares and how is it treated?

The Shaw Family Trust holds 2,000,000 MariMed common shares indirectly. Shaw’s spouse is the trustee and the trust benefits their children. Shaw disclaims beneficial ownership of these securities, meaning he does not claim economic ownership for Section 16 reporting purposes.

Do Timothy Shaw’s newly granted RSUs in MariMed (MRMD) have a purchase price?

The RSU grant shows a transaction price per share of $0.0000, indicating stock-based compensation rather than a cash purchase. The units convert into common stock on a one-for-one basis as they vest on the scheduled dates.